Drug development is a process of discovering and designing new drugs. It involves exploiting biological processes to trigger a therapeutic benefit. A newly developed drug should have many qualities, such as affinity, selectivity efficacy, potency, metabolic stability, and oral bioavailability. Despite many advances in the field of drug technology, drug development is still a complicated process (capital intensive, lengthy, inefficient) and has a slow rate of therapeutic discovery.
The drug development process involves several steps, including the identification and validation of candidates, synthesis and characterization of drugs, screening assays for therapeutic efficiency, etc.
Know anyone building innovative solutions that belong in this 'Drug Development'?
Drug delivery is a method of delivering the therapeutically active drugs to desired location inside the body without causing any side effects. Drug delivery is a concept which includes the dosage form and routes of administration and also the engineering of delivery system of different drugs with same routes. It is a very broad field of research to find different methods of reaching of drug to various parts of the body and this field is likely to expand in future perspective. The drug delivery should be targeted, steady and controlled. The delivery of drugs includes various routes and vehicles to reach the targeted site. Drug delivery technology progressed to become a fundamental tool for the enrichment of pharmacoki-nectic properties of drugs, reducing side effects and bringing about superior clinical results.
The CNS Summit is committed to collaboration among all stakeholders, with the objective of advancing drug development. It is in this spirit of collaboration that we encourage all CNS Summit attendees to actively participate in the Networking meetings.
Industry Dedicated TNBC Forum for Drug Developers Working on Therapeutics for the Niche Aggressive TNBC Tumor Type. This digital conference will explore the key challenges of identifying other druggable molecular targets as well as unveiling the strategies drug developers are employing to improve efficacy, safety, and commercial viability.
Interstitial Lung Disease Drug Development Summit is the only industry focused forum giving you access to the ground-breaking research and radical insights you need to re-energize and revolutionize your drug development strategy against the next pulmonary fibrosis frontier.
This summit is your only and definitive meeting to examine the advancement of innovative therapies and drugs, focusing on the latest research in innovative targeting pathways, unique therapeutics, and new techniques to target mitochondrial dysfunction, whilst evaluating your clinical development landscape.
Prioritize Anti-Infective Drug Development Pipelines that Focus on High-Value Clinical Candidates, Novel Modalities & Effective Strategies that Address Market Sustainability & Aim for Superiority. Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
The industry is adjusting to the pandemic, but FDA approvals could dip this year. Several new drugs for atopic dermatitis may get the agency’s green light.
Like so much else in healthcare and beyond, …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our